Practice Areas

Overview

China Practice, Global Vision
Han Kun is a leading full-service law firm in China. Over the years, Han Kun has been widely recognized as a leader in complex cross-border and domestic transactions.

Culture, Media and Entertainment

Han Kun's culture, media and entertainment team consists of legal professionals possessing extensive expertise and insightful understandings of the culture, media and entertainment industry.

Domestic and International Capital Markets

Han Kun is a leading PRC law firm for capital markets and is recognized as an expert in the field.

Energy, Minerals and Environmental Protection

Our team in energy (including traditional energy and new energy), minerals and environmental protection comprises more than ten experienced professionals who are graduates of top law schools both in China and abroad. They are equipped with excellent legal writing skills and are able to conduct negotiations in English, French, and other foreign languages. Our partners all have more than ten years of practice experience, specializing in energy, minerals, environmental protection industries and other related fields.

Life Sciences and Healthcare

Professional legal team and extensive project experience

Mergers and Acquisitions

Han Kun's mergers and acquisitions practice leads the market in numerous authoritative legal rankings.

Outbound Investment

We represent clients in their overseas equity and asset acquisitions and direct investments.

View All

Professionals

Overview

Precise and Efficient, Professional and Practical
Han Kun has more than 700 professionals located in six offices, in Beijing, Shanghai, Shenzhen, Haikou, Wuhan and Hong Kong. Our lawyers are graduates of top universities and have extensive experience as counsel to both Chinese and foreign clients in complex cross-border transactions.

Han Kun Information

Overview

Legal Mind, Business Sense
Han Kun specializes in a full range of practice areas. Combined with cutting-edge practical experience, our professionals provide clients with timely interpretation of legislative trends, legal practices, and hot legal issues.

News

Insights

Publications

Newsletters

About Han Kun

Overview

We Defend Reason, Full of Passion
Han Kun has always been committed to providing clients with legal services that efficiently and practically solve their complex legal problems in a rapidly evolving legal environment. Our network of offices in Beijing, Shanghai, Shenzhen, Hangzhou, Wuhan, Haikou, Hong Kong, Singapore, New York , Silicon Valley and London
provide seamless, diversified professional legal services across localities and regions to help our clients achieve their objectives and to continually meet new challenges.

Awards and Honors

Social Responsibility

Alumni

Join Us

Overview

Inclusive and People-oriented
Han Kun has a high-quality team of lawyers and offers compensation packages that are highly competitive in the market. Our offices are all located in first-class office buildings and boast superior office environments. We promote harmonious interpersonal relationships, an easy-going work environment, and a people-oriented corporate culture. We look forward to you joining us!

Overview

We look forward to working with you.
Han Kun imparts excellence and pursues brilliance-we are legal counsel you can count on at any time.

Return

Han Kun Hong Kong advised the sole sponsor on the listing of LongBio Pharma (Suzhou) Co., Ltd. on the Main Board of the Hong Kong Stock Exchange

2026-06-05

Han Kun Law Offices LLP ("Han Kun Hong Kong") acted as Hong Kong legal advisor to the sole sponsor, Sinolink Securities (Hong Kong) Company Limited, in connection with the Hong Kong initial public offering under Chapter 18A of the Hong Kong Listing Rules and the Regulation S offering of H shares of LongBio Pharma (Suzhou) Co., Ltd. ("LongBio", Stock Code: 1779). The H shares of LongBio are listed on the Hong Kong Stock Exchange. Sinolink Securities (Hong Kong) Company Limited acted as the sole sponsor and sole sponsor-overall coordinator. Sinolink Securities (Hong Kong) Company Limited, GF Securities (Hong Kong) Brokerage Limited, ABCI Capital Limited, CCB International Capital Limited, Shanxi Securities International Limited and TradeGo Markets Limited acted as the overall coordinators. The initial public offering attracted support from renowned cornerstone investors, including but not limited to OrbiMed Genesis Master Fund, L.P., Value Partners Hong Kong Limited and Fullgoal Fund Management Co., Ltd..

LongBio is a clinical-stage biopharmaceutical company primarily focused on the in-house discovery and development of biopharmaceuticals targeting allergic and autoimmune diseases. LongBio has developed a comprehensive product pipeline for biologic treatments targeting rhinology, dermatology, respiratory, hematology, nephrology and other autoimmune diseases.